Potential Antitumor Effect of Harmine in the Treatment of Thyroid Cancer
Open Access
- 1 January 2017
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 9402615
Abstract
Thyroid cancer is one of the most common types of cancer in endocrine system. In latest studies, harmine has been proved to inhibit the growth of several cancers in vitro and in vivo. In the current study, we evaluated the in vitro and in vivo anticancer efficiency of harmine against thyroid cancer cell line TPC‐1. The in vitro cytotoxicity of harmine evaluated by XTT assay indicated that harmine suppressed the proliferation of TPC‐1 cells in a dose‐ and time‐dependent manner. Moreover, harmine dose‐dependently induced apoptosis of TPC‐1 cells through regulating the ratio of Bcl‐2/Bax. The colony forming ability of TPC‐1 cells was also time‐dependently inhibited by harmine. The inhibitory effects of harmine on migration and invasion of TPC‐1 cells were studied by wound scratching and Transwell assays. In vivo evaluation showed that harmine effectively inhibited the growth of thyroid cancer in a dose‐dependent manner in nude mice. Therefore, harmine might be a promising herbal medicine in the therapy of thyroid cancer and further efforts are needed to explore this therapeutic strategy.Keywords
This publication has 26 references indexed in Scilit:
- Thyroid cancerThe Lancet, 2016
- Harmine Hydrochloride Triggers G2 Phase Arrest and Apoptosis in MGC-803 Cells and SMMC-7721 Cells by Upregulating p21, Activating Caspase-8/Bid, and Downregulating ERK/Bad PathwayPhytotherapy Research, 2015
- Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancerPhytomedicine, 2014
- Harmine hydrochloride inhibits Akt phosphorylation and depletes the pool of cancer stem-like cells of glioblastomaJournal of Neuro-Oncology, 2013
- Clonogenic Assay: Adherent CellsJournal of Visualized Experiments, 2011
- Harmine activates intrinsic and extrinsic pathways of apoptosis in B16F-10 melanomaChinese Medicine, 2011
- Clonogenic assay of cells in vitroNature Protocols, 2006
- Altered Expression of c-IAP1, Survivin, and Smac Contributes to Chemotherapy Resistance in Thyroid Cancer CellsCancer Research, 2006
- Killing cancer cells by flipping the Bcl-2/Bax switchCancer Cell, 2005
- Regulation of BAX and BCL‐2 expression in breast cancer cells by chemotherapyBreast Cancer Research and Treatment, 1999